Q1 2023 Holdings
Filed 2023-05-09 | 6 holdings | $268.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-05-19) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcellx Inc.(ACLX) | COMMON STOCK | 03940C100 | $169.5M | 5,500,007 | 63.1% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $37.7M | 6,526,476 | 14.0% |
| Mineralys Therapeutics(MLYS)A | COM | 603170101 | $28.1M | 1,794,600 | 10.5% |
| ARS Pharmaceuticals(SPRY) | COM | 82835W108 | $26.1M | 4,012,903 | 9.7% |
| Nkarta Inc.(NKTX) | COM | 65487U108 | $4.7M | 1,333,333 | 1.8% |
| Effector Therapeutics Inc | COM | 28202V108 | $2.4M | 6,822,114 | 0.9% |